1. Background {#sec0005}
=============

Macrophages are the ultimate cells of differentiation of the mononuclear phagocyte system. The system further embraces dendritic cells, blood monocytes in circulation and committed myeloid lineage cells in the bone marrow. A marked heterogeneity is displayed by monocytes and dendritic cells in response to environmental stimuli. However, in case of human macrophages, some apprehensions with respect to marked expression motifs of surface markers that delineate different macrophage subsets still persist ([@bib0115]). They form an important component of immunity, playing indispensable characters in innate as well as acquired immunity. Macrophages residing in the tissues are the first barriers of defense against extrinsic invaders and coordinate leukocyte penetration in innate immunity. They subscribe equilibrium between antigen removal by phagocytosis and degradation of microbes, apoptotic cells, and neoplastic cells ([@bib0195]). They are able to acquire well defined phenotypes via phenotypic polarization in response to variegated environmental signals (which could be pathogenic parts or products, injured cells, cellular debris or initiated lymphocytes);and during divergent states of disease ([@bib0575]).

Macrophages amalgamate with B and T cells through systems grounded on the secretion of enzymes, reactive radicals, cytokines, chemokines and metabolites of arachidonic acid (fluid phase mediated mechanism); and through cell to cell communication ([@bib0195], [@bib0735], [@bib0165]). Their activation is dependent upon the signals they receive from their microenvironment which can potentially promote or suppress inflammation leading to smashing of tissue or resuscitation and wound repair, respectively. Thus, the functional phenotype of macrophages acquired in sequel to signals derived from tissues finally trigger, instruct and adjourn the adaptive immune response ([@bib0455]). Moreover, these cells also bestow themselves in homoeostatic functions such as reconstruction of tissues in ontogenesis and metabolic function symphonization ([@bib0195], [@bib0070], [@bib0695]).

Monocytes migrating from blood stream to the peripheral tissues are the progenitor cells of macrophages. The demarcation (differentiation) of these monocytes into macrophages and dendritic cells occurs on exposition to microbial compounds, cytokines favouring inflammation and local growth factors ([@bib0750]). Different regulatory levels and attainment of enhanced resistance to microbes has been achieved by intercellular communication between activated T and B lymphocytes and macrophages. A broader range of trophic functions such as the job of Th2- derived interleukin-4 (IL-4) against extracellular parasitic infection and Th1-derived interferon-gamma (IFN-g) against intracellular infection in acquired immunity and several immunomodulatory agents are responsible for the emergence of the concept of the two correspondents: M1 and M2 macrophages ([@bib0470]). The multiple properties of different phenotypic variants of macrophages possess substantial effects on the residing tissues under different diseased conditions. A specific subset can be either defensive during disease or homeostasis or can be modified in order to complement disease pathogenesis and progression.

2. Heterogeneity in macrophage activation and polarization {#sec0010}
==========================================================

Two hallmarks of macrophages are diversity and plasticity. Classically activated M1 and alternatively activated M2 phenotypes of macrophages portray two zestful changing states of macrophage activation. M1/M2 macrophage polarization is a tightly coordinated process involving numerous pathways of signal transduction, transcriptional and post-transcriptional networks of regulation. M1 macrophages release pro-inflammatory cytokines which retard cellular proliferation surrounding the tissue leading to tissue damage. In contrast, M2 macrophages release anti-inflammatory cytokines which aids in cellular proliferation and promotes wound healing and tissue repair. Any imbalance in macrophage M1/M2 polarization may have detrimental effects resulting in varied diseases or states of inflammation ([@bib0810]).

2.1. Macrophage polarization: classical and alternate activation {#sec0015}
----------------------------------------------------------------

IFN-γ or a combination of IFN-γ with microbial stimuli like lipopolysaccharide (LPS present in the exterior membrane of Gram-negative bacteria) or other cytokines such as GM-CSF (granulocyte-macrophage colony stimulating factor) and TNF-α is responsible for the differentiation of classically activated M1 macrophage ([@bib0470], [@bib0555]). Lipopolysaccharide (LPS), is carried to the cell surface receptor complex via an LPS-binding protein ([@bib0215]). Th1, CD8+ cytotoxic lymphocytes, natural killer (NK) cells, antigen-presenting cells (APC) and B cells, all secrete IFN-γ. IFN-γ is then recognized by IFN-γ receptor (IFNGR), and binding of IFN-γ to IFNGR triggers a series of signal cascades leading to activation and differentiation of M1 macrophages. M1 macrophages possess a specific set of characteristics determined on the basis of tissue location. These characteristics are: a. enhanced secretion of pro-inflammatory cytokines like TNF-α, IL-15, IL-23, IL-1β; b. amplified antigen presenting capacity; c. increased production of iNOS-dependent reactive nitrogen intermediates (RNI) and reactive oxygen intermediates (ROI) and d. aggravated release of IL-12. M1 macrophages, being the first shield to safeguard against intracellular pathogens, display enhanced endocytic functions. Moreover, they secrete high quantities of IL-12 which aids in amplifying Th1 polarization of CD4+ lymphocytes. Thus, M1 macrophages are compelling effector cells, highly efficient of producing abundant pro-inflammatory cytokines and exert microbicidal and cytotoxic activities ([@bib0470], [@bib0025]) ([Fig. 1](#fig0005){ref-type="fig"} ).Fig. 1Classical and Alternate pathway of Macrophage polarization.The figure depicts the pathways involved in macrophage polarization in response to signals received from micro-environment. Classical activation of M1 macrophages is induced by LPS/IFN-γ exposure. Activated M1 macrophages promote enhanced secretion of M1 chemokines, Th1 response elements, i-NOS (inducible nitric oxide synthase) dependent reactive nitrogen intermediates (RNI), high levels of IL-12, IL-23 IL-1β and TNF-α, and low levels of IL-10, which exert pro-inflammatory and cytotoxic effects. They are also involved in tumor suppression and immunostimulation. Alternately activated M2 macrophages are stimulated by IL-4, IL-10, IL-13 and glucocorticoids. IL-4 and IL-13 activates M2a subtype. Presence of immunocomplexes and LPS activates M2b subtype. M2c subtype is induced by IL-10, TGF-β and glucocorticoids. Presence of tumor associated factors triggers the activation of M2d subtype. Activated M2 macrophages enhance the secretion of IL-10 and reduces the secretion of IL-12 and IL-23 due to which they exert anti-inflammatory effects and roles in tissue repair and wound healing. M2d subtype is the prime constituent of TAMs (tumor associated macrophages) and hence promote tumor growth.Fig. 1

The type of activation in which LPS acts as a stimulus for in vitro macrophage activation is known as microbial pathogen associated molecular patterns (PAMPs) based activation ([@bib0305], [@bib0530]). It is also known as innate activation. It resembles the M1 activation but is actually different from M1 macrophages in the way that innate activated macrophages are unable to secrete biologically-active IL-12 as M1 do. They do not possess increased phagocytic activity too ([@bib0770]). Therefore, basing on their activation property, Martinez et al. further categorized these macrophages into M1a (classical) and M1b (innate) type. ([@bib0480]).

There are several stimulatory factors of M2 macrophages some of which are cytokines (IL-4, IL-10 and IL-13); glucocorticoids and immunoglobulin complexes or Toll-like receptor (TLR) ligands. M2 macrophages are known to control inflammation and adaptive Th2 immunity, support angiogenesis, refurnishing and repair of damaged tissue, scavenge debris, and aid tumor progression ([@bib0450]). At the same time, they mediate clearance by expressing the receptor Stabilin-1 which binds the matricellular protein SPARC. Thus, they play a paramount role in harmonized reconstruction of extracellular matrix and repair of damage in normal and tumorous tissues ([@bib0375]). High IL-10, low IL-12 and IL-23 are the specific characteristics of M2 macrophages ([Fig. 1](#fig0005){ref-type="fig"}). Depending upon the gene expression profiles, M2 macrophages are further subdivided into 3 subgroups: M2a, M2b, and M2c ([@bib0470], [@bib0480], [@bib0450]). IL-4 and IL-13, chiefly secreted by mast cells, Th2 cells, and basophils initiate M2a subtype. These two cytokines negatively regulate pro-inflammatory intermediators like TNF-α, IFN-γ, IL-6, IL-12, IL-1β and production of superoxide anions. It has also been found that both IL-4 and IL-13 can also regulate beta2 integrins, MHC-II molecules, metalloproteinase (MMP)-1 and tissue-type plasminogen activator. Furthermore, proteins involved in tissue proliferation and repair; and fibrogenesis are also expressed by M2a cells ([@bib0240], [@bib0130], [@bib0205], [@bib0765]). Exposure to immune complexes in combination with LPS or IL-1R ligand stimulates the subset M2b which is outlined by decreased production of IL-12 and increased production of IL-10 ([@bib0020]). M2b is also favoured by Th2 immune response. The third subtype i.e. M2c is prompted by glucocorticoids, TGF-β or IL-10. It negatively regulates the production of pro-inflammatory cytokines and enhances scavenging activity of debris by M1 macrophages. Wang et al. also identified an additional M2 subset, the M2d macrophage, designated by reduced secretion of IL-12 and enhanced release of IL-10.They exhibit a few attributes of tumor-associated macrophages (TAMs) ([@bib0805]). There are evidences to show that TAMs play a role of key effectors in provoking tumor angiogenesis and progression ([@bib0220]).

2.2. Molecular basis of macrophage polarization {#sec0020}
-----------------------------------------------

M1 macrophages secrete inflammation promoting mediators such as IL-1, IL-6 and tumor necrosis factor (TNF)-α; reactive nitrogen and oxygen intermediates, thereby exerting strong microbicidal and tumoricidal actions. M2 phenotype express cell surface markers such as Arginase 1(Arg1), resistin-like-α (Fizz1), Mrc1 (CD206), chitinase 3-like 3 (Ym1) and anti-inflammatory cytokines such as IL-10. These markers are known to be involved in immunoregulatory activities such as parasite affliction, tissue remodelling and tumor progression ([@bib0190]). Switch over of M1-M2 macrophage phenotype can take place in their specialised tissue microenvironment but this transformation is quite different from that of Th1 and Th2. The leading transcription factors involved in macrophage polarization are STATs (signal transducer and activator of transcription) ([@bib0395], [@bib0595]), NF (nuclear factor)-κβ ([@bib0585]), interferon-regulatory factor (IRFs) ([@bib0660], [@bib0360]), AP 1 (activator protein) ([@bib0670]), PPAR-γ (peroxisome proliferator-activated receptor) ([@bib0580], [@bib0080]) and CREB (cAMP-responsive element-binding protein) ([@bib0635]), which forms a highly coordinated interface with each other to drive macrophage polarization to a particular phenotype in different diseases of inflammation ([Fig. 2](#fig0010){ref-type="fig"} ).Fig. 2Transcription factors involved in macrophage polarization.The figure represents the role of transcription factors involved in M1/M2 polarization and their feedback control. M1 polarization: Binding of IFN-γ to its receptor activates STAT1, involved in transcription of IL-12, NOS-2 and MHC-II genes. Binding of LPS to TLR4 causes activation of IRF5, NF-κβ and AP1, all of which are involved in increased production of proinflammatory cytokines -- IL-1, IL-6,IL-12,IL-23 and TNF. M2 polarization: Binding of free fatty acids to their receptors induces activation of PPARγ, involved in transcription of IL-10 and Arg-1 genes. IL-4/IL-13 triggers the activation of STAT6 and IRF4, responsible for transcription of Arg-1, IL-4α, Ym-1 and fizz-1 genes. TLR4/LPS binding activates CREB, which induces enhanced production of IL-10. M1/M2 polarization also exert feedback regulation mediated by STAT1-STAT6, IRF5-IRF4, NF-κβ-PPARγ, AP1-PPARγ and AP1-CREB. Blocked arrows represent feedback control.Fig. 2

A number of signalling pathways are involved in the process of macrophage polarization. These pathways are well organised in the form of a network co-ordinating appropriate responses to different stimuli. One of the foremost pathway is JAK/STAT pathway which crops up by binding of IFNγ to its cell surface receptor. This causes activation of JAKs leading to dimerization and translocation of STAT1 to the nucleus. STAT1, then initiates transcription of M1-associated genes resulting in production of pro-inflammatory cytokines. On the other hand, STAT6 gets activated by IL-4 and IL-13 to induce M2 polarization. C-Jun-N-Terminal Kinase and MAPK are involved in this pathway. STAT6 activation further activates PPARγ and PPARδ important for M2 polarization. KLF4 cooperates with STAT6 to transform polarization towards M2 phenotype by impairing co activators of NF-κβ. KLF-2 and KLF-4 are the two known factors associated with macrophage activation. Both the factors inhibit NF-κβ activity by impaired recruitment of a NF-κβ transcriptional co activator complex, PCAF/p300 to the target gene promoter ([@bib0445]). Deficiency of KLF4 promotes M1 polarization and inhibits M2 polarization. Thus, it acts as a tipping point in M1/M2 polarization ([@bib0790]). Furthermore, activation of Akt2 via PI3K signalling pathway favours M1 polarization and Akt-1 activation favours M2 polarization. In addition, IRF5 (interferon regulatory factor) enhances the expression of genes encoding IL-12 and represses the genes encoding IL-10, hence promoting M1 polarization. In contrast, IRF-4 facilitates M2 polarization ([@bib0380]) ([Fig. 3](#fig0015){ref-type="fig"} ).Fig. 3Macrophage polarization -- JAK/STAT pathway.Binding of IFNγ, LPS or IL-4/13 to their corresponding surface receptors triggers activation of JAKs (Janus Kinases) which induces activation of STATs (Signal transducer and activators of transcription) and transcription of M1and M2 genes. These genes are also transcribed by the differential activation of Akt1/2 via PI3K or PIP3. Binding of IFNγ to IFNγR1/2 activates JAK1/2, which in turn, activates STAT1/3. STAT1/3 induces activation of NF-κβ. Binding of LPS to TLR4 also activates NF-κβ via adapter proteins MyD88 (Myeloid differentiation primary response 88)/TRIF (TIR-domain containing adapter-inducing interferon-β). KLF4 inhibits the activity of NF-κβ. SOCS3 (suppressor of cytokine signalling 3) negatively regulates the cytokine signalling by binding to JAK2 kinase and inhibiting its activity. Binding of IL-4 to its receptor activates JAK1/2/3 kinases or PI3 kinases. Activated JAKs trigger activation of PPARγ/δ (Peroxisome proliferator-activated receptor gamma) via STAT6, which in turn, activates M2 genes. Akt1 activation promotes activation of M1 genes and Akt2 activation promotes activation of M2 genes.Fig. 3

Additionally, macrophages selectively express certain receptors of the super immunoglobulin family known as Triggering Receptor expressed on myeloid cells (TREM). This family contains two activating receptors -- TREM1 and TREM2. These receptors are known to harmonize inflammatory responses by aggravating the TLR-initiated responses to pathogenic attack, enabling the release of pro inflammatory cytokines and chemokines. Their ligands have not been identified but some of our previous studies have shown that exposure to bacteria/microbial products induce TREM-1 expression. We have also scrutinized the role of lipid mediators in TREM-1 expression. It has been established that on exposure to bacterial and LPS, prostaglandins PGD2, PGJ2 and 15-dPGJ2 (naturally occurring derivatives of prostaglandins) inhibit the expression of TREM-1. This inhibition occurs due to NF-κβ inhibition and Nrf-2 activation i.e. transcriptional factor dependent but is receptor (PGD2 receptors and PPARγ) independent. This prostaglandin mediated inhibition of TREM-1 receptors results in anti-inflammatory effects ([@bib0745]). Previous work carried in our laboratory have also shown that TREM-1 inhibition in macrophages leads to alterations in prime signalling (IKβα, CD14 and MyD88) and effector molecules (MCP-1,IL-6 and IL-1β) downstream of TLR activation. In addition, TREM-1 expression requires TLR activation by specific TLR ligands ([@bib0870], [@bib0855]).

2.3. Metabolic determinants of macrophage polarization {#sec0025}
------------------------------------------------------

Differential metabolism is a peculiar characteristic of different phenotypic variants of macrophages under different conditions of tissue microenvironment and pathophysiological conditions. Differences in sugar, lipid and protein profiles of different phenotypes are observed. Classically activated M1 macrophages persuade an aerobic glycolytic program leading to lactate production. Moreover, PPP (pentose phosphate pathway) is also instigated by IFN-γ or LPS mediated activation. NADPH needed for ROS production is generated by this pathway. The generation of M1 phenotype also requires carbohydrate kinase-like protein (CARKL) involved in catalysis of sedoheptulose-7-phosphate. CARKL is considered to be sedoheptulose kinase choreographing the metabolic controls of pro and anti-inflammatory immune responses in the following manner: the development of M1 phenotype requires down-regulation of CARKL which leads to a reduction in NADH levels in cells over expressing CARKL resulting in a redox shift. PPP (Pentose phosphate pathway) also bestows itself in the reduction of redox couples via NADPH. Thus, M1 activation requires increased GSH and NADH generation whereas M2 activation leads to positive regulation of CARKL which is not a result of elevated GSH or NADH. Further, we can say that differences in metabolic states of macrophage polarization are CARKL dependent ([@bib0245]). In the case of fatty acid oxidation and oxidative metabolism, IL-4 activates STAT-6 which induces mitochondrial respiration. Therefore, M2 activation can direct the pyruvate into Krebs cycle and initiate Electron Transport Chain (ETC) thereby providing energy for tissue remodelling and repair. M1 activation leads to increased glycolysis which aids in microbicidal activity of M1 macrophages and coping up with hypoxia generated in the tissue microenvironment. In lipid metabolism, the pathways activated in M1 macrophages are suppressed in M2 macrophages. Eg: COX-2 is up-regulated in IFN-γ or LPS activated M1 macrophages ([@bib0475]) while COX-1 is down-regulated. On the contrary, COX-1 is up-regulated in IL-4activated M2 macrophages.

The most studied metabolic difference is presented by catabolism of arginine. [L]{.smallcaps}-arginine is a substrate for both i-NOS and arginase-1 (Arg-1). i-NOS produces nitric oxide (NO) and [L]{.smallcaps}-citrulline. NO is the major effector molecule in cytotoxicity mediated by M1 macrophages. Arg-1 produces [L]{.smallcaps}-ornithine, polyamines and urea which is responsible for wound healing actions of M2 macrophages ([@bib0175], [@bib0505]) ([Fig. 4](#fig0020){ref-type="fig"} ).Fig. 4Differential metabolism in macrophage polarization.This figure represents the metabolic differences in macrophage polarization. There is increased glycolytic activity induced by M1 macrophages which leads to higher production of lactate. Increase in NADPH is observed due to PPP (Pentose Phosphate Pathway) which contributes to the generation of ROS (reactive oxygen species) responsible for killing activity exerted by M1 cells. The cytotoxic activity of M1 cells is due to the production of NO (Nitric oxide) which is produced by catabolism of [L]{.smallcaps}-Arginine via i-NOS (Inducible Nitric oxide synthase) dependent pathway. M2 cells are involved in the catabolism of [L]{.smallcaps}-ornithine and polyamines mediated by Arg-1 expression. They also induce β oxidation, Krebs cycle and oxidative phosphorylation. Polyamines and [L]{.smallcaps}-Ornithine generated are involved in tissue repair and regeneration activity of M2 macrophages.Fig. 4

Recently, two additional metabolic pathways involving M2 polarization were also identified. They are glutamine linked metabolic pathway and the uridine diphosphate *N*-acetyl glucosamine (UDP-GlcNAc) pathway. Aspartate-arginine succinate shunt has also been identified in co-ordinating NO and TCA cycles for M1 activation ([@bib0310]).

2.4. Switch over of M1--M2 phenotype {#sec0030}
------------------------------------

Dynamic differentiation of macrophages in response to micro environmental signals enables them to swiftly transform their phenotypes. Under several pathological conditions, stimulation of members of IRF or NF-κβ family in macrophages scan TLR4 or other TLRs and direct macrophages to each of two M1 or M2 phenotype which can then be switched over depending upon the progression states of diseased conditions ([@bib0155], [@bib0160], [@bib0275], [@bib0280], [@bib0570], [@bib0405], [@bib0665]). The spatio-temporal provocation of NF-κβ is a prime regulator of macrophage heterogeneity seen in progression of numerous inflammatory diseases. It can be explained with an example i.e., M1 macrophage stimulation of NF-κβ discerns inflammation linked to cancer during the early stage of tumorigenesis. In contrast, remodelling of macrophages to TAM or M2 type is observed in the late phase of tumorigenesis. These macrophages exhibit decreased capacity of NF-κβ stimulation and increased level of immunosuppression ([@bib0075]). Congruently, in different stages of sepsis, a similar type of situation is displayed wherein M1 mediated NF-κβ activation is convoluted in the early phase of inflammation, while there is preponderance of tumor promoting and inflammation suppressing M2 phenotype in the later phases of inflammation and endotoxin clearance. NF-κβ activation is debilitated in the later phases ([@bib0625]). Another example is RSV infection, the utmost convincing cause of infection in lower respiratory tract occurring in infants and young children. It couples a mixed community of "Th1"and"Th2" cytokines. RSV stimulates the expression of several anti-viral genes such as IFN-b in airway epithelial cells during the initial stages of RSV infection, while during the later stages, it fosters the assertion of numerous pro-inflammatory genes activated by NF-κβ in macrophages by prompting TLR2, TLR3, TLR4, and retinoic acid-inducible gene I (RIG-I). Such expression directs macrophages towards M1 phenotype exhibiting anti-viral and pro-inflammatory activities. Nonetheless, RSV also persuades disease resolution via activation of IL-4 and IL- 13 mediated TLR-4, IL-4Ra/STAT-6, and IFN-b-dependent signalling pathways leading to M2 polarization of alveolar macrophages ([@bib0685]). Besides several other factors, a metabolic determinant phospholipase Cβ2, involved in catalysis of diacylglycerol (DAG) and inositol 1,4,5-triphosphate (PIP3) from phosphatidylinositol 4,5-bisphosphate, has also been involved in switching over of phenotypic determinants of macrophages ([@bib0210]).

3. Macrophages in acute lung injury {#sec0035}
===================================

Acute lung injury or ALI is a traumatic disease which maybe caused by several direct (shock, severe sepsis, pulmonary contusion, gastroesophageal reflux, pneumonia, drug toxicity, transfusion, and acute pancreatitis) or indirect factors like ventilator induced or mechanical injury etc ([@bib0105]). The peculiar characteristics of ALI are enhanced permeability of capillary endothelial and alveolar epithelial cells, scattered pulmonary alveolar and interstitial edema, progressive and refractory hypoxemia and impaired gas exchange all of which expedite arterial hypoxemia,ultimately leading to respiratory failure ([@bib0875], [@bib0760], [@bib0830], [@bib0095], [@bib0005]). The disease pathogenesis is initiated by alveolar septa burst, destruction of the epithelium‐capillary interface, the disgorging of high protein containing fluid, acquittal of inflammation causing chemokines and cytokines alongwith the intrusion of monocytes, neutrophils and other cells causing inflammation ([@bib0590], [@bib0410]). As a result, the pathophysiological conditions such as reduced lung volume, uneven ventilation or perfusion and decreased lung compliance prevails. Acute Respiratory Distress Syndrome (ARDS) is the more relentless form of ALI and can lead to tenacious respiratory failure and high susceptibility to multi-organ functional imbalances or mortality ([@bib0095], [@bib0225]). Several evidences have indicated that macrophages also contributes unequivocally to lung injury by modulating inflammatory responses ([@bib0350], [@bib0465], [@bib0255]). Macrophage polarization is critical in terms of the meticulous benefaction of their different phenotypes to disease pathogenesis. This can be seen in case of ALI which involves an extended or magnified M1 response and faulty M2 mediated repair, whereas in case of chronic diseases like fibrosis and cancer, hyper-responsive, alternatively activated M2 cells dominate.

Two macrophage populations persist in lungs. Alveolar macrophages residing in the tissue acquire lung tissue in the course of early stages of embryogenesis. They endure to be expedient for longer periods and are not restored by monocytes. On the other hand, interstitial macrophages which upon stimulation by various environmental stimuli.are recruited from circulation, have a short life span. Both of them play divergent roles in lung injury. Alveolar macrophages limit neutrophil influx while interstitial macrophages promote neutrophil expulsion ([@bib0500]). The incursion of macrophages inside the lung crop up all along the induction and resolution phase of inflammation. Some of the earlier studies have illustrated that the elevated recruitment of macrophages to the lungs using monocyte chemotactic protein-1 was correlated with mitigated lung injury ([@bib0015]). Nonetheless, it has also been shown by studies based on macrophage depletion techniques, that macrophages contribute equally well in the pathogenesis of lung injury ([@bib0720]). A reason for these unlike effects could be the plasticity or heterogeneity of macrophage polarization, and the scrupulous acquisition or depletion of leukocytes such as monocytes and macrophages in order to promote or retard inflammation. ([@bib0320]). Thus, exploration of the attributes of these subsets is crucial to modify disease −treatment and design therapeutic interventions.

Pathogen recognition, protective host defense by initiation of inflammation, and airway pathogen clearance are the dominant roles of lung macrophages. During lung injury, they recognise microbial impressions through TLRs (toll-like receptors), NODs (NOD-like receptors), intracellular helicases like retinoic acid inducible gene I (RIG-I) as well as various other pattern recognition receptors, and scavenge and phagocytose them. Phagocytosis is mediated by several receptors such as CD13 and receptors for IgG antibodies (FcγRs). When IgG opsonised particles bind to FcγRs present on the surface of a phagocyte, a series of events such as release of pro-inflammatory mediators, production of cytokines and ROS; and antibody-dependent cell mediated cytotoxicity pursues. It has been found that macrophages highly express CD13 which induce ROS production and modulate FcγRs mediated phagocytosis. Usually, it was presumed that changes in expression levels of these receptors determines the extent of phagocytosis. However, it has now been confirmed that macrophage polarization state determines the extent of phagocytosis and ROS production rather than the changes in receptor expression ([@bib0490]). Further, pattern recognition leads to release of cytokines involved in initial response. These cytokines are TNF-α, type I IFN, and IL-1β which upon release, consequently leads to the activation of lung macrophages in an NF-κβ- or IRF-dependent way. These cytokines exhilarate neighbouring AECs (alveolar epithelial cells) and tissue inhabiting macrophages to produce an array of chemokines in either autocrine or paracrine manner. The chemokines released, in turn, arbitrates the avocation of neutrophils, macrophages and lymphocytes to the infection site, eventually leading to pathogen clearance, Reversal of all of the inflammatory initiating steps and ordination of mechanisms of counter regulation leads to termination of inflammation. Repair and settlement of lung inflammation and recurrence of healthy tissue homeostasis is a highly organized process. This process involves interruption of blood vessel displacement of granulocytes, eviction of extravasated fluids and refurbishment of normal permeability of blood vessels, removal of apoptotic neutrophils, cessation of monocyte displacement and their maturation initiation in tissue residing alveolar macrophages, and ultimately, rehabilitation of functional endothelial and epithelial monolayers by "passerby" injury repair. Functional plasticity of alveolar macrophages enables them to acquire different phenotypes during the course of inflammation. The pro- inflammatory or anti-inflammatory or tissue- reparative role of these phenotypes is determined by the signals received from encompassing cells or from the pathogen itself. Thus, the major role of alveolar macrophages is to assimilate these cues during inflammatory progression, to stage a ratchet feedback in order to abort and reconcile alveolar inflammation in the subsequential stages of ALI and to firmly correlate processes of parenchymal repair which is indispensable for restoration of homeostasis ([Fig. 5](#fig0025){ref-type="fig"} ) ([@bib0260]).Fig. 5Macrophages in homeostasis.This figure portrays all the processes involved in cessation and repair of alveolar inflammation after acute inflammatory lung injury Homeostasis is a timely coordinated, active process in which alveolar macrophages are directly or indirectly involved. These processes include blockage of granulocyte (PMN) and monocyte influx from the circulation, phagocytosis of apoptotic polymorphonuclear neutrophils or parenchymal cells, initiation of angiogenesis, repair of the endo-and epithelial barrier by junctional sealing, clearance of alveolar edema, proliferation/differentiation of epithelial progenitor cells including type II alveolar epithelial cells (AEC), removal of fibrin and protein rich edema fluid. These processes are well synchronized and are critical for healthy tissue homeostasis.Fig. 5

One of the important factors necessary for maintaining homeostasis is apoptosis (programmed cell death), which is a highly co-ordinated process carried out to balance cellular proliferation and death. The pro inflammatory macrophages are evacuated by the process of apoptosis and efferocytosis. Delayed apoptosis of these cells result in inflammation and continues with enhanced secretion of pro inflammatory intermediates. In one of our study, we have found that TREM-1 receptors, a member of super immunoglobulin family selectively expressed on macrophages and neutrophils, play an important role as an anti-apoptotic molecule responsible for prolonged survival of inflammatory macrophages. They induce major anti-apoptotic proteins Bcl-2 and Bcl-XL along with reduced activation of Caspase-3 (apoptosis executioner). This induction is Egr-2 mediated which is ERK dependent. Egr proteins are a family of zinc finger transcriptional regulators (Egr 1--4) involved in gene expression during growth, differentiation and survival of a number of cell types ([@bib0855]).

Recently, miRNAs have also emerged to be involved in the establishment of pathogenesis of ALI/ARDS. miR-21 and miR-16 alleviate pulmonary edema associated with ALI. Let-7, miR-155 and miR-146 are associated with inflammation. miR-127 is found to be down modulated in macrophages of mice with bleomycin-induced lung injury in one study ([@bib0830], [@bib0800], [@bib0840], [@bib0825]). In one of the studies carried out on differential miRNA analysis of patients with acute lung injury, it was found that miR-181b inhibits NF-κβ nuclear localization and signalling and hence reducing leukocyte influx and consequently reducing lung injury ([@bib0725]).

4. Polarization of macrophages in inflammatory diseases {#sec0040}
=======================================================

It has been suggested by several studies that during inflammation, monocytes and macrophages express myeloid related proteins (belonging to S100 protein family), at a higher level. Two of them, S100A8 and S100A9 exist as calcium dependent noncovalent homodimers or heterodimers and exhibit pro inflammatory functions. It has been demonstrated that murine S100A8, also called CP-10 is a strong chemotactic factor and promotes continued leukocyte employment. S100A9 and S100A8/9 increase attachment of monocytes to endothelial cells via Mac-1/ICAM-1interactions ([@bib0640]). S100A8 proteins have been reported to stimulate chemotactic migration and persuading macrophages to induce pro-inflammatory mediators such as TNF-α ([@bib0675]). Some of the exemplary inflammatory diseases are discussed here.

5. Infection by various pathogens {#sec0045}
=================================

A pathogenic attack on a tissue calls for the recruitment of monocytes in circulation, which then -- differentiate into macrophages depending upon the stimulus they receive from the pathogen of the environment. In the early stage of bacterial infection, macrophages express M1 phenotype ([@bib0435]). The macrophage populations scan their resident tissue of PAMPs (pathogen-associated molecular patterns) and DAMPs (danger associated molecular patterns). They respond to these stimuli by initiating an acute inflammatory cascade ([@bib0820]). When the PAMPs present in bacteria are identified by pattern recognition receptors like TLRs (Toll-like receptors), macrophages are stimulated and polarized towards M1 phenotype thereby leading to high production of pro-inflammatory intermediators such as IL-1, TNF-α, and NO (nitric oxide), which kill the conquering pathogens and trigger adaptive immunity ([@bib0325]). This scheme of inflammation is also involved in infection with *Salmonella typhi*, the initial infection stages of *Mycobacterium ulcerans, Mycobacterium avium* and *Mycobacterium tuberculosis* ([@bib0700]). Any delay in control of macrophage-mediated inflammation leads to the discharge of a cytokine blast which plays an important role in the pathogenesis of severe sepsis ([@bib0730]). To counterbalance the exorbitant inflammation, macrophages go through apoptosis or transform their phenotype towards M2 type to defend the host from extreme injury and trigger wound healing ([@bib0545]).

In case of Bronchiectasis (a chronic devitalizing airways disease designated by a domino effect of inflammation and bacterial squatting), it was found that inflammatory effects are enhanced by the presence of certain commensal bacteria such as *Stromatosus mucilaginosus* which could provide a cordial environment for the growth of other microbes such as *Pseudomonas aeruginosa* contributing to lung infection. *S.mucilaginosus* activates TLR2 to induce host immune response by releasing pro inflammatory cytokines from M1 macrophages ([@bib0850]).

On the other hand, M2 macrophages are involved in repressing inflammation and promote tissue healing in a viral infection. In acute viral infection, stimulation by chemokines directs the recruitment of macrophages from circulation and polarizes them to a particular phenotype depending upon the type of chemokines released. These macrophages act as a robust exterminator of conquering pathogens by secreting inflammatory intermediators, such as i-NOS (inducible nitric oxide synthase) and TNF-α ([@bib0715]) though, the tissue-inhabiting macrophages behave differently in viral infections. As for e.g in case of influenza virus infection, M2 phenotype accelerates the resolution of inflammation by elevating the process of phagocytosis ([@bib0270]). In severe acute respiratory syndrome (SARS)-Cov infection, STAT dependent pathway of macrophage polarization insulates the host from development of chronic fibrotic lung disease. M2 macrophages are critical for this process ([@bib0605]). In addition, mixed M1 and M2 macrophages are associated with severe respiratory syncytial virus (RSV) induced bronchiolitis ([@bib0685]). Moreover, it has been found that the activity of cyclooxygenase-2 inhibitor is impaired by IL-4-STAT6 dependent M2 macrophage polarization. Cyclooxygenase -2 inhibitor is known to exaggerate inflammation, epithelial damage and M2 macrophage expression in lungs. For this reason, it has also been proposed as a treatment strategy ([@bib0415]).

5.1. Pulmonary toxicity {#sec0050}
-----------------------

The continuous exposure of lungs to extrinsic environment makes it notably susceptible to the injurious effects of acid aerosols, inhaled gases, radiation, particles and systemically administered drugs such as bleomycin and nitrogen mustard ([@bib0390]). These agents may instigate acute injury and pneumonitis succeeded by pulmonary fibrosis. The severity of the pathologic response is the outcome of the dose, duration and the nature of the toxic agent. Alveolar and interstitial macrophages most prominently behave as the first line of defense against xenobiotics, although macrophages are located all over the lungs. Several receptors such as TLRs Fc portion of IgG, IgA, and IgE; and other pattern-recognition receptors are present on lung macrophages. These receptors, upon binding of the suitable ligand cause their activation and dispense proteases, ROS and RNS, pro-inflammatory lipids, and cytokines steered to safeguard the host. Moreover, they can phagocytose a number of remote substances ([@bib0385]).

Ingestion of mineral dusts like silica and asbestos also leads to acute pulmonary injury succeeded by fibrosis. In case of such pulmonary injury, lung macrophages produce mediators which initiate and perpetuate inflammation along with transformation of mesenchymal cells ([@bib0195], [@bib0480], [@bib0525]). These inhaled particles bind with the MARCO (macrophage receptor with a collagenous structure) receptors present on the surface of macrophages and are phagocytosed by alveolar macrophages ([@bib0235]). However, these inert particles are indigestible; hence triggering of macrophage breach leads to a burst of proteases and chemokines which intensifies inflammation, subsequently leading to tissue injury. Latest evidences have demonstrated that it is an NLRP3 inflammasome dependent response. Inflammasome is a multiprotein scaffold present in cytosol, and is critical for inflammatory response activation ([@bib0110]). Silica activated alveolar macrophages also release mitogens, TGF-β and chemotactic factors for lung fibroblasts which aid in promoting lung fibrosis ([@bib0365]). When animals are subjected to bleomycin and radiation, macrophages and intermediators of inflammation to lung fibrosis contribute in a similar fashion ([@bib0550], [@bib0090]).

Evidences have clearly stated the part of M2 macrophages in the augmentation of chronic lung disease from studies that states pulmonary fibrosis worsens in animals over expressing IL-10 or IL-13 ([@bib0045], [@bib0400]) but decreases in animals that (a) are treated, with serum amyloid P (an inhibitor of M2 macrophage development in the lung) ([@bib0550]); (b) lack M2 chemokine CCR2 ([@bib0600]) or are IL-4 deficient ([@bib0495]); or (c) have been administered with anti-CCL2/MCP-1 gene therapy ([@bib0300]). Impressively, it has been shown that alternatively activated M2 macrophages are cynical in retarding actions of M1 phenotype and an equilibrium in their action determines the output of the harmful response. These results are in concord with reports stating that development of fibrosis in a granulomatous lung disease model is analogous with up-regulation of arginase, the M2 marker, and that over expression of NOS-2 and reduced fibrosis is due to administration of IL-12 ([@bib0265]).

5.2. Allergy/asthma {#sec0055}
-------------------

Allergy is associated with M2 polarization of macrophages driven by Th2 cells and products ([@bib0335], [@bib0485]). It represents an instance of type 2 inflammation driven by IL-4/IL-13. IL-4 inducible chemokines acting on CCR4 (e.g., CCL22) has been noted to crook macrophage function ([@bib0775]). It has been evidenced that pathogenesis of allergy involves effective role of chitin and arginase-dependent M2 pathways ([@bib0880], [@bib0630]). However, there are certain evidences stating that allergic inflammation can also be driven by the inflammasome/IL-1/Th17 pathway ([@bib0030]). In addition, allergic inflammation also incriminates IL-18, (a Th1-associated cytokine) ([@bib0780]). Therefore, it is possibly unsurprising that mixed phenotype of macrophages are involved in allergic inflammation.

Asthma is a chronic inflammatory disease prevalent in both developing and developed countries. Disturbances in the reconciliation of pulmonary macrophage phenotypes contributes to the pathogenesis of asthma ([@bib0510]). M2 phenotype of macrophages, appreciative of tissue repair and refurbishment of homeostasis in the lung tissue microenvironment, play a leading role in asthma. However, airway hyper-responsiveness may result due to imprudent M2 macrophages which increase cell recruitment and mucus secretion. It has been found that the inflammatory response, collagen deposition and pathophysiological process of asthma is accelerated on transferring M2 macrophages into the lungs of fungus-induced asthmatic model of mice ([@bib0515]). With increasing research in macrophage polarization, several evidences have been found to reassure that M1 macrophages subscribe to the progression of asthma. In cases of more complicated asthmatic forms, particularly glucocorticoid therapy resistant patients, macrophages adopt M1 phenotype resulting in high production of pro-inflammatory mediators, including TNF-α, IL-1β, NO, intensification of the lung injury and acceleration of the airway remodelling ([@bib0330]). This can be explained as NO released by M1 macrophages mediates oxidative DNA damage, inflammation and aggravated mucus secretion which intensifies lung injury in murine model of allergen induced airway disease ([@bib0565]). Thus, exploring the ways to maintain the order of regulation of pulmonary macrophage phenotypes would provide us the way for development of improved therapeutic strategies.

It has been recently found that some of the prospects of asthma are also associated with miRNA deregulation. miR-145 reduces pro-inflammatory cytokines IL-13, IL-5 and hence diminishes asthmatic symptoms. miR-146a decreases the secretion of several pro-inflammatory cytokines and chemokines. miR-21 targets IL-21, the prime cytokine implicated in Th1 cell polarization. Similarly, negative regulation of let-7 reduces the level of IL-13, an important molecule of allergic events exhibiting a role in Th2 response. ([@bib0370], [@bib0560])

5.3. Sepsis {#sec0060}
-----------

Sepsis is an immoderate inflammatory response and an immunosuppressive disorder that arises due to infection that gets into the blood or acute insults. ([@bib0285]). Secondary infection is the most prominent cause of severe sepsis or septic shock related mortality. It is a result of debilitation of the host immune response due to apoptosis of immune cells and high production of regulatory T cells ([@bib0315]) and myeloid derived suppressor cells ([@bib0140]). M2 phenotype is commonly involved in the development of sepsis related immunosuppressive state. It has been evidenced by Porta and his co researchers that p50 subunit of the NF-κβ is the main controller of this process. They have also stated that LPS-resistant macrophages and M2 macrophages exhibit similar characteristics ([@bib0625]). Therefore, revealing the mechanisms of macrophage polarization in differential progression of sepsis and maintaining its equilibrium may cater a probable therapeutic target for septic complications.

For the treatment of sepsis related ARDS, strategies based upon deletion of Akt2 kinase have been used in mice. These strategies work on enhancing M2 polarization of alveolar macrophages while totally negating M1 polarization. However, innate immune response required for effective bacterial clearance by alveolar macrophages is impeded on complete arrest of classical macrophage activation. Hence, its use is limited to only aseptic conditions and not live bacteria. Therefore, therapeutic strategies based on augmenting M2 activation while retaining M1 plasticity would be more favourable for the treatment. Immunoproteasome-mediated inhibition seems to be a more appreciative approach according to some authors ([@bib0520]). The proteasome is involved in regulating intracellular signalling by degradation of a number of signalling mediators. Immunoproteasome activity increases on stimulation of all three subunits. The three subunits, LMP, LMP7 and multicatalytic endopeptidase complex-like 1 are induced by bacterial LPS or IFNγ which drives alveolar macrophage polarization towards M1 phenotype. Thus, M1phenotype prompts all the three subunits of immunoproteasome. On the other hand, alternatively activated M2 macrophages increases immunoproteasome activity by aggravating expression of LMP2 and LMP7 subunits only ([@bib0120]).

5.4. Chronic obstructive pulmonary disorder (COPD) {#sec0065}
--------------------------------------------------

Chronic exposure of the airways to irritants such as cigarette smoke leads to epithelial cell injury, destruction of pulmonary capillary vasculature, acceleration of epithelial cell senescence and airway remodelling resulting in the loss of lung compliance which ultimately leads to COPD ([@bib0440], [@bib0145]). The prolonged persistence of inflammation is an important specifying feature of COPD ([@bib0615]). It has been found that a group of endothelial-derived microparticles (EMPs) increase in patients with stable COPD and during exacerbation. These EMPs contain E-selectin, platelet endothelial cell adhesion molecule and vascular endothelial cadherin. Lung destruction and air flow limitation can be correlated with levels of EMPS in stable COPD ([@bib0355], [@bib0755]). Most of the alveolar macrophages are normally non-polarized but in COPD, there is a significant increase in macrophage polarization and co-expression of M1 and M2 macrophages ([@bib0050]). An important feature of COPD pathogenesis is the release of a number of inflammatory mediators such as TNF-α, IL-1β, GM-CSF, TGFβ, and CXCL-8, by lung epithelial cells. These mediators act in both autocrine and paracrine manner. The main cause of fibrosis development is airway remodelling which is induced by TGFβ mediated myofibroblast differentiation.The severity of airway obstruction can be correlated with the level of TGFβ in the small airway epithelium of COPD patients ([@bib0785]).

Zaynagetdinov et al. ([@bib0865]) demonstrated that chronic airway inflammation is a NF-κβ driven process which leads to the alternative activation of alveolar macrophages, resulting in TGFβ/IL-10/retinoic acid-dependent generation and maintenance of Foxp3+ Tregs. In addition, they also demonstrated that despite the presence of chronic airway inflammation, the development and maintenance of an immunosuppressive microenvironment in the lungs is induced by the amplified expression of TGFβ and IL-10 by alveolar macrophages. Thus, these molecules and pathways could be potential targets to reduce the excessive risk of lung cancer in individuals accompanied by chronic lung inflammation related to COPD.

In a recent study based on miRNA/mRNA microarray expression analysis on human alveolar macrophages from smokers and non-smokers it was found that -- reduced expression of miR-152 up regulates the expression of MMP12, responsible for development of emphysema. This study demonstrated a correlation between macrophage polarization and miRNA deregulation ([@bib0200]). Another study demonstrated that miR-146a regulates the duration and intensity of inflammation by down regulating COX2 and PGE2 which are the important mediators of tissue inflammation ([@bib0655]).

5.5. Tuberculosis {#sec0070}
-----------------

Tuberculosis (TB) is a worldwide spread infectious disease, caused by *Mycobacterium tuberculosis* (Mtb). The precise mechanisms of its pathogenesis are unspecified. Macrophages play an important role in eliminating Mtb in the way as Mtb are inhaled as droplets from air are phagocytosed by alveolar macrophages in the lung and killed by ROS in the phagolysosome resulting in the recruitment of mononuclear cells ([@bib0060]). They are the cells of first line of immune defense to confront and eliminate mycobacteria ([@bib0055]). Resistance against intracellular parasites and acceleration of inflammatory responses is mediated by classically activated (M1) macrophages ([@bib0055]). On the other hand, alternatively activated M2 macrophages participate in tissue repair, tumour progression, restraint of inflammation, and promotion of Th2 responses ([@bib0435]). Macrophage polarization is a very important aspect of disease progression and resolution of inflammatory or infectious processes ([@bib0380], [@bib0705], [@bib0065]). In fact, it has also been shown that anti-microbial activity and cytokine production during TB granuloma formation is modulated by macrophage polarization ([@bib0460], [@bib0290]). Thus, it might also play an important role in Mtb infection ([@bib0645], [@bib0650]). Host protection is impeded by type I IFN which is being evidenced to play an undesirable role in pathogenesis of tuberculosis by interfering IFN-γ dependent immunity ([@bib0520]).

It is well evidenced that fusion of lysosomes with Mtb-containing phagosomes and iNOS up-regulation is triggered by M1 polarized macrophages ([@bib0705]). Up-regulation of microbicidal enzymes and iNOS generation is also associated with M1 macrophages. Importantly, utilization of TLR2 signalling pathway is also ensured by M1 polarization. It has also been suggested that MyD88-dependent TLR2 signalling is inhibited by Mtb ([@bib0610]). Lim et al. suggested that during Mtb infection, the TLR2/MyD88 signalling pathway is relatively more associated with M1 macrophage activation rather than M2 polarization ([@bib0425]). Therefore, inhibition of the intracellular survival of Mtb would be furnished by M1 macrophage activation via the TLR2 signalling pathway which would be beneficial for the host. Cell death by apoptosis is also an important mechanism of host defense against Mtb infection, but the underlying molecular mechanisms are not clear. Intrinsic and extrinsic signals can trigger apoptosis, and such signals can also activate macrophages.

5.6. Bronchopulmonary dysplasia (BPD) {#sec0075}
-------------------------------------

It is a chronic lung disease prevalent in premature babies. The causative factors of BPD are life saving interventions including high airway pressures and oxygen tension in the course of mechanical ventilation. The pathogenesis of BPD consist of postnatal suspension of alveolarisation along with noticeable decrease in type I alveolar epithelial cells (AEC1); and reduction in septal crust density ([@bib0420]).

Macrophages are significant components of both neonatal and adult lung immunity. Neonates are vulnerable to several pathogenic infections such as pneumonia leading to localized lung inflammation which is considered very important in the pathogenesis of BPD ([@bib0710]) ([@bib0345]). Neonatal monocytes respond normally to such pathogenic attacks leading to release of inflammatory cytokines such as TNFα and IL-6 but preterm infants have decreased IL-10 release ([@bib0295]). Aggravated release of these pro-inflammatory cytokines may have a deleterious effect on host's health ([@bib0740]).

It has been shown by our group that hyperoxia or hyperoxia plus LPS exposure leads to aggravation of inflammation induced-M1phenotype and suppression of M2 phenotype in macrophages. The suggested causal factor behind these modifications in macrophage polarization state from M2 to M1 is the lack of BRP-39 in the developing lung ([@bib0740]). BRP-39 (Breast Regression Protein-39) is a chitinase-like protein present in a number of cells such as monocytes and macrophages ([@bib0230]). There are several other factors which have potential clinical relevance with neonatal inflammatory imbalances during pulmonary development. One of the factors is Activin A which is a member of TGFβ family and is implicated in repair and survival of type-II AEC ([@bib0085]). Inhibition of Activin A signalling provides protection against hyperoxia induced pathological lung remodelling, growth retardation and leukocyte infiltration. Moreover, it also inhibits anti-inflammatory M2 phenotype by down regulating IL-10 production *in-vitro*, suggesting their role in progressive BPD ([@bib0710]). Thus, addressing the inter-link between inflammatory imbalances in lung development of neonates and macrophage modulation may provide us a potential interposition to cure BPD.

6. Repolarization of macrophages -- potential therapy {#sec0080}
=====================================================

Reprogramming of macrophages to switch their phenotype could be a potential therapeutic strategy ([@bib0135]). This can be explained with the help of few examples such as (a) Activin A, a pluoripotent TGFβ family growth and differentiation factor, regulates the cellular growth of a number of cell types and attunes myeloid cell release of cytokines and chemokines. It is also inculcated in macrophage polarization by stimulating Arg-1 expression and hindering expression of IFN-γ-induced NO synthase 1 suggesting its role as a Th2 cytokine and thereby promoting alternate activation of M2 macrophages in mouse. Contrarily, in humans, macrophage polarization is directed towards M1 phenotype by high levels of Activin A ([@bib0710]). (b) Schistosoma mansoni -- derived soluble egg antigens (SEAs) initiates immune responses involving M2 macrophages and can forestall inflammatory responses. Therefore, its use may be advantageous in treatment of chronic inflammatory diseases ([@bib0815]). Some of the phenotype switch strategies are based upon inhibition of mitochondrial respiration thereby blocking the M2 phenotype and initiating M1 phenotypic state. Propelling oxidative metabolism towards M1 macrophage enhances M2 macrophage activation. Haschemi etal measured the effects on macrophage polarization by changing CARKL expression. It was found that upon LPS stimulation, constitutional CARKL expression decreased glycolysis in macrophage cell lines resulting in activation of M2 macrophages. On the contrary, RNAi mediated abscission of CARKL expression drive macrophages towards M1 phenotype before LPS stimulation ([@bib0245]).

As suggested by above illustrations, it can be stated that manipulation of macrophage polarization is clinically successful to some extent. At the same time, it is also well established that many pathological conditions express a mixed population of macrophages. Thus, the influence of disease evolutionary changes and progression should be taken into account very cautiously on a case-to-case basis.

6.1. Glutathione: role in macrophage repolarization {#sec0085}
---------------------------------------------------

In the last few years, it has been found that reduced glutathione (GSH) is also cardinally involved in adaptive immunity by affecting the activities of macrophages and lymphocytes. It is a ubiquitous non-protein thiol present in animal cells and is involved in numerous cellular functions such as synthesis and degradation of DNA and proteins; and toxin and carcinogen detoxification. Depletion of GSH in APC (antigen presenting cells like macrophages) is related to defects in antigen processing and also inhibits Th-1 associated cytokine release. In mouse, depletion of GSH in APC reduces secretion of IL-12 (responsible for synchronization of IFN-γ production) resulting in switching over of Th1 cytokine profile towards Th2 cytokine profile ([@bib0690], [@bib0620], [@bib0535], [@bib0540]). It also plays a key role in determining the type i.e. Th1 or Th2 response in human alveolar macrophages ([@bib0150]). Hence, we can say that M1 cells have an elevated ratio of GSH/GSSG or reduced −to-oxidized glutathione wherein IFN-γ and IL-4 exert antagonistic effects on reductive status. Further, by modifying the ratio of intracellular GSH/GSSG, M2 macrophages can be reprogrammed to M1 phenotype. It has been accomplished by using γ-Glutamylcysteinylethyl ester (γ-GCE) which could strengthen Th1 response via high production of IL-12 ([@bib0340]). It is also observed that low GSH/GSSG ratio favours M2 macrophages. As a consequence, measurement of GSH level of human and murine macrophages can provide us a steady biomarker. *Mycobacterium tuberculosis* infection is a compelling example of modification of intra-cellular redox state by intra-macrophage pathogen leading to alteration of T-cell responses. Alam et al. have illustrated the manipulation of redox state of macrophages using N-acetyl cysteine (NAC, a glutathione precursor) ([@bib0010]).

Other molecules that can also be used to fortify Th1 response are I-152 (a cysteine precursor involved in synthesis of glutathione) ([@bib0795]); n-butanoyl GSH derivative (GSH-C4); GSH-monoethyl ester (GSH-OEt) and LPS- induced IL-12 p40 protein production in human macrophages ([@bib0180]). Therefore, these molecules can be considered as new immunomodulators ([@bib0185]).

7. mi-RNA (micro RNA) and macrophage plasticity {#sec0090}
===============================================

Micro RNAs or miRNAs are highly conserved and regulatory small non coding RNAs \~ 22nts in length. They are indistinguishable to intermediators of RNA interference and attune various physiological processes like immune cell activation, differentiation and apoptosis. They bind to complementary base pairs on target mRNAs leading to inhibition of translation. Three miRs, miR-155, miR-124 and miR-223 have been identified to be intricated in macrophage polarization ([@bib0890]). miR-124 is known to promote latency of macrophages and clampdown of experimental autoimmune encephalomyelitis. It binds three presumptive binding sites present in the 3′ UTR (untranslated region) of CCAAT/enhancer binding protein-α (C/EBPα) (a monocytic transcription factor) leading to inhibition of mRNA translation. High expression of miR-124 up regulates M2 associated cytokines such as Arg-1 and TGF-β1, and decreases activation of myelin-specific T cells and notable disease annihilation ([@bib0790]). Expression of miR-155 is initiated by bacterial LPS. It limits expression of C/EBPβ and assists M1 macrophage polarization ([@bib0250]), miR-223, also favours M1 polarization and adjourns M2 polarization on LPS/IL-4 stimulation. Pknox1, gene has been known to be implicated in miR-223 mediated macrophage polarization ([@bib0890]). miRNAs such as miR-146, miR-9, miR-125b and miR-155 ameliorate TLR4/IL-1R signalling pathways in macrophages and monocytes suggesting macrophage phenotype transformation from pro-inflammatory to anti-inflammatory types ([@bib0035]). miR-17, miR-20a and miR-106a down regulates the expression of signal regulatory protein α (SIRPα), a macrophage differentiation related marker ([@bib0885]). miR-21 and miR-98 down regulates the expression of inflammatory genes in monocytes and macrophages ([@bib0430]). Let-7c has been found to be associated with macrophage modulation. It is highly expressed in M2 macrophages ([@bib0040]). miR-155 has also been established as a key molecule in shifting macrophage polarization towards M1-type ([@bib0100]). One of our study has shown that up-regulation of miR-155 is responsible for the pro inflammatory effects of TREM-1 receptors selectively expressed on macrophages. These changes are mediated by down-regulation of SOCS-1(suppressor of cytokine signalling), target of miR-155. Our data shows thatTREM-1gene silencing leads to survival improval in LPS-induced neutrophillic lung inflammation. It could also improve mitochondrial bioenergetics which would be immunometabolically advantageous to mitochondrial respiration with low rate of O~2~ consumption. We have also demonstrated a novel nanomicellar (LP17 nanomedicine) approach to inhibit TREM-1 effects. Thus, our study suggests TREM-1 to be a potential therapeutic target for treatment of ARDS ([@bib0860]).

8. Compounds affecting macrophage polarization {#sec0095}
==============================================

Some natural compounds affect macrophage polarization to exert their anti inflammatory effect. Shikonin, the major component of root extracts of *Lithospermum erythrorhizon*, inhibits the transcriptional activity of the TNF-α promoter suggesting its potential as an anti-inflammatory therapeutic ([@bib0125]). Chlorogenic acid is a phenolic compound found in coffee, apples, pears and green tea which exerts anti-inflammatory effects through NF-κB inhibition of PGE synthesis and COX-2 and by suppressing JNK/AP-1 activation ([@bib0835]). It has been reported that ACA, a glycoprotein obtained from the mycelium extract of *A*. *camphorata* is capable of macrophage activation via TLR2/MyD88-dependent pathway. It is thus able to exhibit a pro inflammatory response favouring M1 phenotype of macrophages ([@bib0680]). A new, sulfur-containing compound, Onionin A isolated from acetone extracts of bulbs of onion (*Allium cepa*), possess the ability to suppress tumor-cell proliferation by inhibiting the polarization of M2 alternatively activated macrophages ([@bib0170]). Curcumin (diferuloylmethane), the yellow pigment of turmeric, a prime ingredient of curry spice is also known to exhibit anti-inflammatory effects induced by inhibition of TREM-1 receptors on LPS exposure. It inhibits the p300 activity in TREM promoter resulting in epigenetic changes involving hypoacetylation of histone 3 and 4 in the lysine residues of chromatin. This leads to reduced binding of p65 component of NF-κβ to TREM-1 promoter resulting in dampening of TREM-1 expression ([@bib0845]).

9. Conclusions {#sec0100}
==============

Macrophages are important cellular components of both innate and acquired immunity. They are implicated in tissue repair and wound healing activities and also act as a shield against invading pathogens and toxicants. The diverse functions of macrophages are attributable to the heterogeneity in their activation which is a stimulus driven process. Classically activated M1 macrophages are capable of cytotoxicity whereas alternatively activated M2 macrophages are capable of suppressing inflammation and initiation of wound repair. These activities are a result of highly regulated signal pathways involving a number of molecular intermediators such as growth factors, cytokines, oxidants and lipid mediators released by different macrophage subpopulations. These processes are tightly regulated under the conditions of homeostasis. Compromise of control mechanisms, asymmetric activity of macrophages, plethoric release of pro-inflammatory, cytotoxic and fibrogenic products bolster tissue injury and pathogenesis of chronic inflammatory disease. Apart from transient, plastic and irreversible M1-M2 phenotypic transformations, macrophages also have the ability to rapidly switch over to a different phenotype or repolarise in response to the micro environmental stimuli received from encompassing tissues. In addition, several natural compounds possess the ability to modulate macrophage polarisation in order to exhibit their anti-inflammatory, anti-oxidative and anti-carcinogenic actions. Furthermore, a contemporary class of non-coding RNAs, called micro-RNAs or miRNAs are also involved in activation as well as suppression of genes of immune system cells. Thus, miRNA target prediction and comprehensive characterization of differentially expressed miRNAs could help us to elucidate their specific roles in lung injury. Although several studies have clearly indicated the role of resident and recruited alveolar macrophages in process of repair initiation in infectious as well as inflammatory diseases, a lot more remains to be versed about the cellular communication between macrophages and several anti-inflammatory cells. Other questions that need to be answered are the molecular markers involved in macrophage polarization. Thus, finding answers to these questions can pave us a way to manipulate the mechanisms of polarization in order to improve the disease conditions.
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